Nothing Special   »   [go: up one dir, main page]

ATE230609T1 - Verfahren zur behandlung von entzündungen und zusammensetzungen dafür - Google Patents

Verfahren zur behandlung von entzündungen und zusammensetzungen dafür

Info

Publication number
ATE230609T1
ATE230609T1 AT96909862T AT96909862T ATE230609T1 AT E230609 T1 ATE230609 T1 AT E230609T1 AT 96909862 T AT96909862 T AT 96909862T AT 96909862 T AT96909862 T AT 96909862T AT E230609 T1 ATE230609 T1 AT E230609T1
Authority
AT
Austria
Prior art keywords
serp
compositions
treating inflammation
methods
biologically active
Prior art date
Application number
AT96909862T
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Viron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viron Therapeutics Inc filed Critical Viron Therapeutics Inc
Application granted granted Critical
Publication of ATE230609T1 publication Critical patent/ATE230609T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96909862T 1995-03-27 1996-03-26 Verfahren zur behandlung von entzündungen und zusammensetzungen dafür ATE230609T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/411,043 US5939525A (en) 1995-03-27 1995-03-27 Methods of treating inflammation and compositions therefor
PCT/US1996/004054 WO1996030042A2 (en) 1995-03-27 1996-03-26 Methods of treating inflammation and compositions therefor

Publications (1)

Publication Number Publication Date
ATE230609T1 true ATE230609T1 (de) 2003-01-15

Family

ID=23627329

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909862T ATE230609T1 (de) 1995-03-27 1996-03-26 Verfahren zur behandlung von entzündungen und zusammensetzungen dafür

Country Status (11)

Country Link
US (2) US5939525A (de)
EP (1) EP0817646B1 (de)
JP (1) JPH11503122A (de)
AT (1) ATE230609T1 (de)
AU (1) AU5323396A (de)
CA (1) CA2214988A1 (de)
DE (1) DE69625682T2 (de)
DK (1) DK0817646T3 (de)
ES (1) ES2187646T3 (de)
PT (1) PT817646E (de)
WO (1) WO1996030042A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
WO2001030379A2 (en) * 1999-10-27 2001-05-03 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
AU1943501A (en) * 1999-12-02 2001-06-12 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US20040029244A1 (en) * 2000-05-25 2004-02-12 Ben-Tsion Williger Phospholipase d effectors for therapy and screening
JP2004509171A (ja) * 2000-09-29 2004-03-25 ゾーン、　ロバート　ズィー． 炎症及び免疫反応の治療方法及びその組成物
EP1331943A4 (de) * 2000-10-11 2005-01-26 Viron Therapeutics Inc Nukleinsäure-moleküle und polypeptide zur immunmodulation
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
ES2287192T3 (es) * 2000-12-04 2007-12-16 Viron Therapeutics, Inc. Proteina inmunomoduladora derivada del virus de tumor del mono de yaba.
CA2440042C (en) * 2001-03-05 2011-09-27 Transtech Pharma, Inc. Carboxamide derivatives as therapeutic agents
WO2004033705A2 (en) * 2001-10-10 2004-04-22 Mount Sinai School Of Medicine Of The City University Of New York Viral interferon antagonists and uses therefor
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
AU2003280252A1 (en) * 2002-11-01 2004-05-25 Alexandra R. Lucas Viral serpin regulation of inflamation
US7285530B2 (en) * 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
WO1992006706A1 (en) * 1990-10-16 1992-04-30 John Lezdey Treatment of inflammation
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
EP0754054B1 (de) * 1994-04-08 2002-07-03 Viron Therapeutics, Inc. Antirestenoses protein

Also Published As

Publication number Publication date
US5917014A (en) 1999-06-29
PT817646E (pt) 2003-04-30
JPH11503122A (ja) 1999-03-23
ES2187646T3 (es) 2003-06-16
CA2214988A1 (en) 1996-10-03
DE69625682D1 (de) 2003-02-13
WO1996030042A2 (en) 1996-10-03
WO1996030042A3 (en) 1996-11-21
EP0817646A2 (de) 1998-01-14
AU5323396A (en) 1996-10-16
DE69625682T2 (de) 2003-10-02
US5939525A (en) 1999-08-17
DK0817646T3 (da) 2003-04-22
EP0817646B1 (de) 2003-01-08

Similar Documents

Publication Publication Date Title
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE69835823D1 (de) Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
SE9603725D0 (sv) New teatment
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
NO984198L (no) FremgangsmÕte for behandling av aggresjon
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
MY109685A (en) Method for treating hepatitis b carriers with minimal disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0817646

Country of ref document: EP

REN Ceased due to non-payment of the annual fee